Requirement for coronary sinus lead interventions and effectiveness of endovascular replacement during long-term follow-up after implantation of a resynchronization device

Europace

Volumn 11, Issue 5, 2009, Pages 607-611

  Borleffs, C Jan Willem ^a   Van Bommel, Rutger J ^a   Molhoek, Sander G ^a   De Leeuw, Joost G ^a   Schalij, Martin J ^a   Van Erven, Lieselot ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac resynchronization therapy; Failure; Heart failure; Lead; Left ventricular lead

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CORONARY SINUS; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; NERVE STIMULATION; PHRENIC NERVE PACING; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; CORONARY SINUS; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART VENTRICLES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PHRENIC NERVE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 66749120862     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun395     Document Type: Article

References (16)

1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346: 1845-53.
2. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-33.
3. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De MT et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
4. Gras D, Leclercq C, Tang AS, Bucknall C, Luttikhuis HO, Kirstein-Pedersen A. Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study. Eur J Heart Fail 2002;4:311-20.
5. Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40:111-8.
6. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
7. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 2003;289:730-40.
8. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003;289:2685-94.
9. Gras D, Bocker D, Lunati M, Wellens HJ, Calvert M, Freemantle N et al. Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace 2007;9:516- 22.
10. Leon AR, Abraham WT, Curtis AB, Daubert JP, Fisher WG, Gurley J et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol 2005;46:2348- 56.
11. Albertsen AE, Nielsen JC, Pedersen AK, Hansen PS, Jensen HK, Mortensen PT. Left ventricular lead performance in cardiac resynchronization therapy: impact of lead localization and complications. Pacing Clin Electrophysiol 2005;28:483-8.
12. Leclercq F, Hager FX, Macia JC, Mariottini CJ, Pasquie JL, Grolleau R. Left ventricular lead insertion using a modified transseptal catheterization technique: A totally endocardial approach for permanent biventricular pacing in end-stage heart failure. Pacing Clin Electrophysiol 1999;22:1570- 5.
13. Szili-Torok T, Foldesi C, Kardos A, Szekely A, Kassai I. A novel approach for endo-cardial resynchronization therapy: transapical implantation of left ventricular pacing lead. Heart Rhythm 2008;5:S96.
14. van Gelder BM, Scheffer MG, Meijer A, Bracke FA. Transseptal endocardial left ventricular pacing: an alternative technique for coronary sinus lead placement in cardiac resynchronization therapy. Heart Rhythm 2007;4:454-60.
15. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1-62.
16. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.